For MedPro Rx patients receiving IVIg or Factor Replacement Therapy, the following pharmaceuticals and specialized pharmacy services are provided if needed:

	Anti-Infectives:	• Antibiotics • Antivirals • Antifungals
	Biological Response Modifiers:	• Epogen® (epoetin alfa) • Neupogen® (G-CSF) • Leukine® (GM-CSF) • Proleukin® (interleukine) • Neulasta® (pegfilgrastim) • Aranesp® (darbepoietin)
	Chemotherapeutic Agents:	• Methotrexate (various) • Lupron® (leuprolide) • Novantrone® (mitoxantrone) • Cyclophosphamide (Cytoxan® and others)
	Disease Modifying Antirheumatics:	• Enbrel® (etanercept) • Remicade® (infliximab) • Humira® (GM-CSF)
	Enzyme Replacement:	• Aldurazyme® (laronidase) • Cerezyme® (imiglucerase for injection) • Fabrazyme® (agalsidase beta) • Myozyme® (alglucosidase alfa)
	Immune Modulators:	• Avonex® (interferon beta-1a) IM • Betaseron® (interferon beta-1b) • Copaxone® (glatiramer) • Peg-Intron® (peginterferon alfa-2b) • Pegasys® (peginterferon alfa-2a) • Rebif® (interferon beta-1a) SQ • Roferon-A® (interferon alfa-2a)® • Rebetron® (Rebetol® - ribavirin plus • Copegus™ - ribavirin, USP) • Rebetol® (ribavirin) • Copegus™ (ribavirin, USP)
	Steroids:	• Methylprednisolone (various)

*Aranesp®, Enbrel, Epogen®, Neulasta®, Neupogen® and Novantrone® are registered trademarks of AMGEN®; Leukine® and Betaseron® are registered trademarks of Berlex; Proleukin® is a registered trademark of Chiron Corporation; Roferon-A®, Pegasys®, Rebetron® and Rebetol® are registered trademarks of Roche; Lupron® is a registered trademark of TAP Pharmaceutical Products, Inc.; Cytoxan® is a registered trademark of Mead Johnson; Avonex® is a registered trademark of Biogen®, Inc.; Copaxone® is a registered trademark of Teva® Pharmaceutical Industries, Ltd.; and Peg-Intron® is a registered trademark of Schering Corporation, Rebif® is a registered trademark of Serono, Inc. Humira® is a registered trademark of Abbott Laboratories.